MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dysarthria"

  • 2019 International Congress

    The origin of stimulation-induced dysarthria in ET patients after VIM/PSA-DBS: Atactic, spastic or both?

    H. Jergas, J. Petry-Schmelzer, J. Becker, T. Thies, J. Steffen, V. Visser-Vandewalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate the origin of stimulation-induced dysarthria (SID) in essential tremor (ET) patients with bilateral deep brain stimulation (DBS) in the ventral intermediate nucleus…
  • 2019 International Congress

    Unclear Pronunciation of Stop Consonant Sounds in Patients with Parkinson’s Disease Following Deep Brain Stimulation

    T. Sakurai, T. Yamamoto, Y. Yamanaka, S. Hirano, M. Abe, Y. Uji, A. Murata, Y. Higuchi, S. Kuwabara (Chiba-Ken, Japan)

    Objective: To clarify the characteristics of changes in stop consonant articulation in PD subjects before and after DBS and compared with control group by using…
  • 2019 International Congress

    Differential effects of stimulation amplitude and lead laterality of deep brain stimulation of the subthalamic nucleus on speech and Parkinsonian motor symptoms

    E. Tripoliti, B. Veggia, M. Hariz, P. Limousin (Reggio Emili, Italy)

    Objective: To examine the differential effects of subthalamic nucleus deep brain stimulation (STN DBS) amplitude (high and low) and lead laterality (Left-Right-bilateral) on speech intelligibility…
  • 2019 International Congress

    Stability and reliability of objective measures of speech in Parkinson’s Disease over 12 months

    M. Magee, J. Tamplin, C. Marigliani, F. Baker, M. Morris, A. Vogel (Melbourne, Australia)

    Objective: To describe the stability and reliability of acoustic measures of speech in Parkinson’s Disease (PD) at 3 and 12 months. Background: Speech biomarkers hold…
  • 2019 International Congress

    Global implementation of efficacious voice treatment for Parkinson’s disease: LSVT LOUD in Germany, France and Japan

    L. Ramig, T. Brauer, C. Airiau, M. Fujiu-Kurachi (Boulder, CO, USA)

    Objective: This study was designed to evaluate the implementation of an efficacious voice treatment, Lee Silverman Voice Treatment (LSVT LOUD), into scope of clinical practice…
  • 2019 International Congress

    Interactive dual task exercises delivered via smart speaker: a feasibility study

    J. Dean, J. Domingos (Aurora, CO, USA)

    Objective: Assess the feasibility of using commercially available smart speakers to provide exercise activities that provide interactive feedback to individuals with Parkinson’s. Background: A growing…
  • 2019 International Congress

    Can we hear pathology in premanifest Huntington’s disease? Acoustic and listener-based analysis of speech

    J. Chan, C. Shirbin, J. Stout, A. Vogel (Melbourne, Australia)

    Objective: The present study evaluated the ability of acoustic and listener-based perceptual measures to differentiate speech deficits in the premanifest and early stages of HD…
  • 2019 International Congress

    Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation

    J. Maas, N. de Vries, B. Bloem, J. Kalf (Nijmegen, Netherlands)

    Objective: To study the effectiveness of personalized speech therapy delivered by telerehabilitation, aiming to improve hypokinetic dysarthria in patients with Parkinson’s disease (PD), regardless of…
  • 2019 International Congress

    Speech impairment as a marker of clinical changes in premanifest Huntington’s disease

    J. Chan, Y. Lie, J. Stout, A. Vogel (Melbourne, Australia)

    Objective: Speech disturbances have been described in premanifest Huntington’s Disease (HD). Yet a recent systematic review and meta-analysis highlighted disagreement in the literature regarding the…
  • 2019 International Congress

    Speech and swallowing disorders in Parkinson’s disease – is there a link?

    N. Madetko, S. Budrewicz (Wrocław, Poland)

    Objective: To determine: 1.If acoustic speech analysis can be a method of oropharyngeal dysphagia detection. 2.Which acoustic parameters and to what extent correlate with fiberoptic…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 16
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley